Learn More
Description
Cefotaxime binds to penicillin-binding proteins (PBPs), which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. As a result, bacteria lyse due to cell wall autolytic enzymes. Cefotaxime blocks the division of cyanobacteria and lower plant organelles/plastids such as the photosynthetic organelles of Glaucophytes and chloroplasts of bryophytes. Cefotaxime is used to treat a variety of bacterial infections:
- Good coverage against most Gram-negative bacteria, with the notable exception of Pseudomonas
- Effective against most Gram-positive cocci, except for Enterococcus
- Active against penicillin-resistant strains of Streptococcus pneumoniae
- Modest activity against the anaerobic Bacteroides fragilis
- In meningitis, cefotaxime crosses the blood–brain barrier better than cefuroxime
Specifications
Specifications
| Physical Form | Powder |
| Quantity | 1 g |
| Solubility Information | Soluble in water (0.05gm/1mL, clear, light yellow solution). |
| Formula Weight | 477.45 |
| Percent Purity | ≥95% |
Safety and Handling
| Recommended Storage | Store at 4°C, protect from light. |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.